Biochemistry, Genetics and Molecular Biology
Protease
97%
Macroglobulin
96%
Epidermal Growth Factor Receptor
88%
Protease Inhibitor
78%
T Cell
71%
Conformation
69%
Conformational Change
59%
Thioester
49%
Agonist
45%
Proteinase Inhibition
45%
Monospecific Antibody
43%
Carcinoembryonic Antigen
42%
Cryoelectron Microscopy
42%
Antineoplastic Activity
41%
Disulfide
33%
Complement Component 3
28%
Protein Catabolism
27%
Mouse
26%
Secretion (Process)
26%
PD-L1
26%
Cytotoxicity
24%
Transforming Growth Factor
24%
Solution and Solubility
24%
Tumor Immunity
24%
Monoclonal Antibody
24%
Protein Aggregation
21%
Dimerization
21%
Cryo-Electron Microscopy
21%
Induced Mutation
21%
Serine Protease
21%
Subtilisin
21%
Murine
21%
Extremophile
21%
Diabody
21%
Co-Receptor
21%
Cluster of Differentiation
21%
Cell Membrane
21%
Enzymatic Hydrolysis
21%
Protease
21%
C3b
18%
Pharmacokinetics
15%
Anaphylatoxin
14%
Enzyme
12%
Mass Spectrometry
11%
Cancer Immunotherapy
10%
Wild Type
10%
N-Terminus
10%
C-Terminus
10%
Single-Domain Antibody
10%
Cell Activation
9%
Immunology and Microbiology
T Cell
100%
Conformation
69%
Monospecific Antibody
53%
Conformational Transition
47%
Agonist
45%
Immunotherapy
42%
Chimeric Antigen Receptor
42%
Mouse
42%
Antineoplastic Activity
41%
Protein Degradation
35%
Carcinoembryonic Antigen
28%
Epidermal Growth Factor
28%
Programmed Death-Ligand 1
28%
Cryo-Electron Microscopy
26%
Single-Domain Antibody
26%
Wild Type
25%
Complement Component 3
25%
C3b
25%
Monoclonal Antibody
24%
Tumor Antigen
23%
Binding Antibody
21%
Extremophile
21%
Cross-Presentation
21%
Murine
21%
Tumor Immunity
21%
Albumin Antibody
21%
CD19
21%
Environmental Temperature
21%
Microorganism
21%
Chimeric Antigen Receptor T-Cell
21%
Severe Acute Respiratory Syndrome Coronavirus 2
21%
Neutralizing Antibody
21%
Cytotoxic T Cell
21%
Dendritic Cell
21%
Cluster of Differentiation
21%
Proteinase Inhibition
21%
Cell Membrane
21%
Blocking Antibody
21%
Anaphylatoxin
21%
Bispecific Antibody
19%
Solution and Solubility
17%
Pharmacokinetics
17%
Xenograft
15%
Cancer Cell
12%
Amino Terminal Sequence
12%
Cytotoxic T-Cell
12%
Chimeric Antigen Receptor T-Cell Therapy
10%
Cancer Immunotherapy
10%
Arthritis
10%
Blood Plasma
10%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
55%
Proteinase
42%
Alpha 2 Macroglobulin
42%
Chimeric Antigen Receptor
42%
Proteinase Inhibitor
34%
Epidermal Growth Factor Receptor
28%
Immunotherapy
24%
Albumin Antibody
21%
Leukemia Relapse
21%
Synapsin I
21%
Hydroxyl Group
21%
Thioester
21%
Transforming Growth Factor
21%
Cornea Dystrophy
21%
Blocking Antibody
21%
Histidine
12%
Dimer
12%
Thermolysin
12%
Malignant Neoplasm
8%
Leukemia
8%
Tumor Microenvironment
7%
Serine
7%
Monoclonal Antibody
7%
Mouse
7%
Blinatumomab
7%
Solid Malignant Neoplasm
6%
Tumor Antigen
6%
Metalloproteinase
6%
